Drug Repurposing News and Research

RSS
Could a fungus-derived compound reduce hyperinflammation in severe COVID-19?

Could a fungus-derived compound reduce hyperinflammation in severe COVID-19?

Eldelumab and Fenofibrate show potential for COVID-19

Eldelumab and Fenofibrate show potential for COVID-19

SARS-CoV-2 enzyme inhibitors among drugs screened for repurposing

SARS-CoV-2 enzyme inhibitors among drugs screened for repurposing

Study explores therapeutic potential of exploiting autophagy cascade against COVID-19

Study explores therapeutic potential of exploiting autophagy cascade against COVID-19

Scientists identify many existing drugs with antiviral activity against coronavirus

Scientists identify many existing drugs with antiviral activity against coronavirus

ALG-097111 potently inhibits SARS-CoV-2 replication in Syrian Hamster model in vivo

ALG-097111 potently inhibits SARS-CoV-2 replication in Syrian Hamster model in vivo

COLCORONA study shows that colchicine can reduce complications in certain COVID-19 patients

COLCORONA study shows that colchicine can reduce complications in certain COVID-19 patients

Vagus nerve stimulation may be a potential adjunct therapy for COVID-19

Vagus nerve stimulation may be a potential adjunct therapy for COVID-19

Repurposed gout medication (probenecid) shows potent inhibition of SARS-CoV-2 replication

Repurposed gout medication (probenecid) shows potent inhibition of SARS-CoV-2 replication

The potential therapeutic value of CDK6 inhibitors in critical COVID-19

The potential therapeutic value of CDK6 inhibitors in critical COVID-19

Could graphene oxide nanosheets be an effective SARS-CoV-2 antiviral in PPE?

Could graphene oxide nanosheets be an effective SARS-CoV-2 antiviral in PPE?

SARS-CoV-2 Nsp2 structure revealed by cryo-EM and AI

SARS-CoV-2 Nsp2 structure revealed by cryo-EM and AI

New computational tool helps screen molecules for their potential COVID-fighting properties

New computational tool helps screen molecules for their potential COVID-fighting properties

Hepatitis C antivirals synergize with remdesivir to inhibit SARS-CoV-2 in vitro

Hepatitis C antivirals synergize with remdesivir to inhibit SARS-CoV-2 in vitro

What is the role of nanotechnology in the current COVID-19 outbreak?

What is the role of nanotechnology in the current COVID-19 outbreak?

Researchers examine potential SARS-CoV-2 antivirals using a drug repurposing library

Researchers examine potential SARS-CoV-2 antivirals using a drug repurposing library

Two repurposed drugs and a blue dye show potential as SARS-CoV-2 entry inhibitors

Two repurposed drugs and a blue dye show potential as SARS-CoV-2 entry inhibitors

Celastrol shows potential anti-SARS-CoV-2 activity

Celastrol shows potential anti-SARS-CoV-2 activity

NIH funds large Phase 3 clinical trial to test repurposed drugs for treating COVID-19 symptoms

NIH funds large Phase 3 clinical trial to test repurposed drugs for treating COVID-19 symptoms

Screening drug candidates for COVID-19 treatment using computational methods

Screening drug candidates for COVID-19 treatment using computational methods